Visit WTR Logo
Subscribe now

Law & Policy

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show
14 Nov 2019

Legal landscape more rational now but will shift back, says Facebook IP supremo

Get your deals done now before the market begins to rebalance in favour of patent owners, Allen Lo advises licensees while speaking on panel at the annual IP Dealmakers conference

13 Nov 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options

Latest

View all
12 Nov 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016 Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

8 Nov 2019

Micron lawyers say Hong Kong is too risky for trade secret exchange

But a US federal judge ruled last month that UMC and Fujian Jinhua can review Micron’s evidence against them in the Special Administrative Region Read more

7 Nov 2019

The USPTO's consultation on patent issues relating to AI seeks answers on key questions

Artificial intelligence has the potential to change the entire nature of the invention process and, therefore, the criteria under which patents are awarded Read more

News

View all
2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

30 Oct 2019

IPBC Asia comes to a brilliant end in Tokyo

A hugely successful conference that attracted a record attendance is now over after a day of talk about 5G licensing, the Chinese and Japanese IP landscapes, data, litigation and a whole lot more Read more

29 Oct 2019

Highlights from Day One of this year’s IPBC Asia

New market entrants, 5G futures, trade secret challenges, top dealmaking tips, the end of the foundry patent war, a new billion dollar IP fund and much more discussed at the sell-out event in Tokyo Read more

26 Oct 2019

Japan is the unheralded centre of Asia’s patent market

Long-term filing declines and a staid litigation environment mask the fact that the patent strategies pursued by the country’s elite companies are becoming more aggressive and dynamic Read more

Analysis

View all
6 Nov 2019

We’re keeping a very close eye on Arthrex, says Iancu at IAM event in Washington DC

Major Federal Circuit decision on PTAB judges leaves stakeholder community looking for answers and, possibly, to a statutory solution  Read more

6 Nov 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate Read more

5 Nov 2019

Top tips for patenting personalised medicine 

As medical treatments become increasingly bespoke, we reveal some best practices to help inventors secure the highest quality patents possible. Read more

5 Nov 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds Read more

Insights

View all
24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

1 Apr 2019

Even as the storm clouds gather, Huawei’s enviable IP position means that it cannot be ignored in 5G

Storm clouds are gathering over the most talked about company in the telecoms sector but as we embark on a new era of mobile technology, Huawei still enjoys a number of notable advantages. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

Trending

1

Catch up on the most important life sciences IP developments from the past month

2

The USPTO's consultation on patent issues relating to AI seeks answers on key questions

3

Micron lawyers say Hong Kong is too risky for trade secret exchange

4

We’re keeping a very close eye on Arthrex, says Iancu at IAM event in Washington DC

5

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

Find an expert

Christof Augenstein
Partner
Dusseldorf, Germany
Kather Augenstein Rechtsanwälte PartGmbB
View full biography
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.